SAM
KITE

Sandell Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Sandell Asset Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-128,000
Closed -$23M – 47
2017
Q3 		$23M Buy
+128,000
New +$17.8M 2.63% 18

Sandell Asset Management's KITE Position: Q4 2017 in Review

Sandell Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 128,000 shares — an estimated $23M sold.

Sandell Asset Management first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $23M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Sandell Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Sandell Asset Management sold 128,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $23M.
  • Sandell Asset Management first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Sandell Asset Management's Kite Pharma, Inc. position peaked at $23M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Sandell Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.